Sino Biopharmaceutical Limited
SBMFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $10 | $9 | $9 | $10 |
| Short-Term Investments | $5 | $2 | $8 | $6 |
| Receivables | $5 | $5 | $5 | $4 |
| Inventory | $2 | $2 | $2 | $2 |
| Other Curr. Assets | $3 | $3 | $2 | $1 |
| Total Curr. Assets | $25 | $24 | $26 | $24 |
| Property Plant & Equip (Net) | $10 | $10 | $9 | $9 |
| Goodwill | $1 | $1 | $1 | $1 |
| Intangibles | $2 | $0 | $1 | $1 |
| Long-Term Investments | $26 | $25 | $17 | $19 |
| Tax Assets | $0 | $0 | $1 | $0 |
| Other NC Assets | $1 | $4 | $9 | $8 |
| Total NC Assets | $41 | $40 | $38 | $37 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $65 | $64 | $64 | $61 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $2 | $2 |
| Short-Term Debt | $8 | $11 | $10 | $7 |
| Tax Payable | $0 | $1 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $10 | $10 | $8 | $7 |
| Total Curr. Liab. | $20 | $23 | $20 | $15 |
| LT Debt | $2 | $1 | $4 | $6 |
| Deferred Rev, NC | $0 | $1 | $1 | $1 |
| Deferred Tax Liab, NC | $0 | $1 | $1 | $1 |
| Other NC Liab. | $1 | $0 | $0 | $0 |
| Total NC Liab. | $3 | $3 | $6 | $7 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $23 | $25 | $26 | $23 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $6 | $10 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $25 | $24 | $23 | $27 |
| AOCI | $0 | -$10 | -$10 | -$9 |
| Other Equity | $6 | $11 | $6 | $12 |
| Total Equity | $32 | $30 | $30 | $30 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $11 | $8 | $8 | $7 |
| Total Liab. & Tot. Equity | $65 | $64 | $64 | $61 |
| Net Debt | $0 | $3 | $5 | $3 |